Kemp K - Search Results

1

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Hares K, Kemp K, Loveless S, Rice CM, Scolding N, Tallantyre E, Robertson N, Wilkins A. Hares K, et al. Among authors: kemp k. J Neurol. 2021 Jun;268(6):2175-2184. doi: 10.1007/s00415-020-10373-w. Epub 2021 Jan 23. J Neurol. 2021. PMID: 33484325 Free PMC article.

2

Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.

Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N. Wilkins A, et al. Among authors: kemp k. Stem Cell Res. 2009 Jul;3(1):63-70. doi: 10.1016/j.scr.2009.02.006. Epub 2009 Mar 27. Stem Cell Res. 2009. PMID: 19411199 Free article.

3

Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival.

Kemp K, Hares K, Mallam E, Heesom KJ, Scolding N, Wilkins A. Kemp K, et al. J Neurochem. 2010 Sep;114(6):1569-80. doi: 10.1111/j.1471-4159.2009.06553.x. Epub 2010 Aug 19. J Neurochem. 2010. PMID: 20028455 Free article.

4

Stem cells in genetic myelin disorders.

Kemp K, Mallam E, Scolding N, Wilkins A. Kemp K, et al. Regen Med. 2010 May;5(3):425-39. doi: 10.2217/rme.10.10. Regen Med. 2010. PMID: 20455653 Review.

5

Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.

Mallam E, Kemp K, Wilkins A, Rice C, Scolding N. Mallam E, et al. Among authors: kemp k. Mult Scler. 2010 Aug;16(8):909-18. doi: 10.1177/1352458510371959. Epub 2010 Jun 11. Mult Scler. 2010. PMID: 20542920

6

Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells.

Kemp K, Gray E, Mallam E, Scolding N, Wilkins A. Kemp K, et al. Stem Cell Rev Rep. 2010 Dec;6(4):548-59. doi: 10.1007/s12015-010-9178-6. Stem Cell Rev Rep. 2010. PMID: 20683679

7

Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells.

Kemp K, Gordon D, Wraith DC, Mallam E, Hartfield E, Uney J, Wilkins A, Scolding N. Kemp K, et al. Neuropathol Appl Neurobiol. 2011 Feb;37(2):166-78. doi: 10.1111/j.1365-2990.2010.01122.x. Neuropathol Appl Neurobiol. 2011. PMID: 20819172 Free PMC article.

8

Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment.

Witherick J, Wilkins A, Scolding N, Kemp K. Witherick J, et al. Among authors: kemp k. Autoimmune Dis. 2010 Dec 15;2011:164608. doi: 10.4061/2011/164608. Autoimmune Dis. 2010. PMID: 21197107 Free PMC article.

9

Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function.

Gray E, Ginty M, Kemp K, Scolding N, Wilkins A. Gray E, et al. Among authors: kemp k. Eur J Neurosci. 2011 Apr;33(8):1421-32. doi: 10.1111/j.1460-9568.2011.07637.x. Epub 2011 Mar 7. Eur J Neurosci. 2011. PMID: 21375604

10

Neurofilament dot blot assays: novel means of assessing axon viability in culture.

Hares K, Kemp K, Gray E, Scolding N, Wilkins A. Hares K, et al. Among authors: kemp k. J Neurosci Methods. 2011 Jun 15;198(2):195-203. doi: 10.1016/j.jneumeth.2011.03.025. Epub 2011 Apr 1. J Neurosci Methods. 2011. PMID: 21459112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

446 results

Search Page

Filters